Since 2015

Since 2015

Xianglong Group was founded in 2015 as a corporate entity specializing in the research, development, production, quality control, and sales of standard reference materials/samples for life health sciences. The group comprises three subsidiaries—Longqiang Pharmaceutical, Longhui Bio, and Xianglong Pharmaceutical—along with two renowned standard reference brands: 科析化学® (QCC) and 龙汇生物® (FDR).
Longqiang Pharmaceutical specializes in the biosynthetic R&D of standard materials/samples for life health sciences. Led by a team of postdoctoral researchers with overseas experience, the company focuses on cutting-edge technology and market demands, continuously introducing innovative and distinctive products to the brand.
Longhui Biotech, as a self-owned brand production entity, specializes in the full-process production, quality control, and assignment of standard materials. The company obtained CNAS 17025 laboratory accreditation in 2023 and CNAS 17034 standard material producer accreditation in 2026, forming a closed-loop dual-system of "testing and analysis—standard material production—assignment." It is committed to providing high-purity, stable, and compliant impurity standard materials and traceability solutions for the analysis and quality control of impurities throughout the drug lifecycle, including innovative drug R&D, generic drug consistency evaluation, and pharmaceutical quality management.
Xianglong Pharmaceutical, as the sales entity of the renowned brand 科析化学® (QCC) and 龙汇生物® (FDR) for pharmaceutical impurity standards within the group, provides standard materials and scientific research products to pharmaceutical R&D enterprises and institutions. Its main products include: drug standards, impurity references, plant monomers and references, pesticide references, and consumables. Since its establishment, the company has established long-term and stable business relationships with numerous renowned pharmaceutical enterprises, universities, and research institutes both domestically and internationally. Xianglong Pharmaceutical offers over 60,000 catalog products and more than 3,000 analytical verification methods, serving over 5,000 domestic and international clients.